Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 86Recruiting 30Unknown 25Terminated 18Withdrawn 10Active not recruiting 9Not yet recruiting 4Suspended 1

Sponsor Class

OTHER 4INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 4Head & Neck 1

Conditions

Breast Neoplasms 469Neoplasms 327Colorectal Neoplasms 236Carcinoma, Non-Small-Cell Lung 233Lung Neoplasms 200Prostatic Neoplasms 179Carcinoma, Hepatocellular 173Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 114Uterine Cervical Neoplasms 110Rectal Neoplasms 105Multiple Myeloma 93Recurrence 88Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 78Neoplasm Metastasis 76Ovarian Neoplasms 75Brain Neoplasms 69Colonic Neoplasms 68Glioblastoma 66Esophageal Neoplasms 66Triple Negative Breast Neoplasms 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Small Cell Lung Carcinoma 54Disease 54Motor Activity 53Hematologic Neoplasms 53Glioma 46

Interventions

Drug Therapy 2cemiplimab 1Tissue Banks 1Pemetrexed 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Mesothelioma, Malignant × Clear all
NCT07550049 2026-04-24

COMETH

University of Kansas Medical Center

Not yet recruiting
110 enrolled
Head & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Head and Neck Neoplasms, Small Cell Lung Carcinoma

NCT07234058 2026-02-11

LAG-MAPS

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
126 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

National Cancer Center, China

Phase 1/2 Not yet recruiting
55 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06416930 2024-05-16

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
59 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡